Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAGLUMET: Envarsus vs Prograf in Kidney Transplant Recipients
NCT05396898Phase 4Completed
- Sponsor
- University Hospital Tübingen
- Start
- Dec 2020
- Primary completion
- Aug 2023
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in diabetes mellitus (DM), sponsored by University Hospital Tübingen. Started Dec 2020; status: completed.
02
Drugs
tacrolimus
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT05396898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05396898.